MAGI3-AKT3 Fusion in Breast Cancer Amended

Overview

Journal Nature

Specialty Science

Date 2015 Apr 17

PMID 25877206

Citations 15

Authors

Juan-Miguel Mosquera

Sonal Varma

Chantal Pauli

Theresa Y MacDonald

Jossie J Yashinskie

Zsuzsanna Varga

Andrea Sboner

Holger Moch

Mark A Rubin

Sandra J Shin

Affiliations

Soon will be listed here.

Citing Articles

Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy.

Li Q, Li Z, Luo T, Shi H Mol Biomed. 2022; 3(1):47.

PMID: 36539659 PMC: 9768098. DOI: 10.1186/s43556-022-00110-2.

GeneChip expression profiling identified as a potential therapeutic target in TNBC cells.

Gao X, Yang Z, Xu C, Yu Q, Wang M, Song J Ann Transl Med. 2022; 10(6):274.

PMID: 35433966 PMC: 9011253. DOI: 10.21037/atm-22-757.

A New Story of the Three Magi: Scaffolding Proteins and lncRNA Suppressors of Cancer.

Kotelevets L, Chastre E Cancers (Basel). 2021; 13(17).

PMID: 34503076 PMC: 8428372. DOI: 10.3390/cancers13174264.

Multi-Gene Testing Overview with a Clinical Perspective in Metastatic Triple-Negative Breast Cancer.

Dameri M, Ferrando L, Cirmena G, Vernieri C, Pruneri G, Ballestrero A Int J Mol Sci. 2021; 22(13).

PMID: 34281208 PMC: 8268401. DOI: 10.3390/ijms22137154.

AKT3 Expression in Mesenchymal Colorectal Cancer Cells Drives Growth and Is Associated with Epithelial-Mesenchymal Transition.

Buikhuisen J, Gomez Barila P, Torang A, Dekker D, de Jong J, Cameron K Cancers (Basel). 2021; 13(4).

PMID: 33673003 PMC: 7918753. DOI: 10.3390/cancers13040801.

References

Berger M, Lawrence M, Demichelis F, Drier Y, Cibulskis K, Sivachenko A . The genomic complexity of primary human prostate cancer. Nature. 2011; 470(7333):214-20. PMC: 3075885. DOI: 10.1038/nature09744. View

Mosquera J, Sboner A, Zhang L, Chen C, Sung Y, Chen H . Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosomes Cancer. 2013; 52(11):1075-87. PMC: 3889711. DOI: 10.1002/gcc.22102. View

Pal S, Childs B, Pegram M . Triple negative breast cancer: unmet medical needs. Breast Cancer Res Treat. 2010; 125(3):627-36. PMC: 3244802. DOI: 10.1007/s10549-010-1293-1. View

Dobin A, Davis C, Schlesinger F, Drenkow J, Zaleski C, Jha S . STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2012; 29(1):15-21. PMC: 3530905. DOI: 10.1093/bioinformatics/bts635. View

Robinson D, Kalyana-Sundaram S, Wu Y, Shankar S, Cao X, Ateeq B . Functionally recurrent rearrangements of the MAST kinase and Notch gene families in breast cancer. Nat Med. 2011; 17(12):1646-51. PMC: 3233654. DOI: 10.1038/nm.2580. View

Mosquera J, Sboner A, Zhang L, Kitabayashi N, Chen C, Sung Y . Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma. Genes Chromosomes Cancer. 2013; 52(6):538-50. PMC: 3734530. DOI: 10.1002/gcc.22050. View

Perner S, Demichelis F, Beroukhim R, Schmidt F, Mosquera J, Setlur S . TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. Cancer Res. 2006; 66(17):8337-41. DOI: 10.1158/0008-5472.CAN-06-1482. View

Craig D, OShaughnessy J, Kiefer J, Aldrich J, Sinari S, Moses T . Genome and transcriptome sequencing in prospective metastatic triple-negative breast cancer uncovers therapeutic vulnerabilities. Mol Cancer Ther. 2012; 12(1):104-16. DOI: 10.1158/1535-7163.MCT-12-0781. View

Pflueger D, Terry S, Sboner A, Habegger L, Esgueva R, Lin P . Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing. Genome Res. 2010; 21(1):56-67. PMC: 3012926. DOI: 10.1101/gr.110684.110. View

10.

Sboner A, Habegger L, Pflueger D, Terry S, Chen D, Rozowsky J . FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data. Genome Biol. 2010; 11(10):R104. PMC: 3218660. DOI: 10.1186/gb-2010-11-10-r104. View

11.

Bauer K, Brown M, Cress R, Parise C, Caggiano V . Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry. Cancer. 2007; 109(9):1721-8. DOI: 10.1002/cncr.22618. View

12.

Banerji S, Cibulskis K, Rangel-Escareno C, Brown K, Carter S, Frederick A . Sequence analysis of mutations and translocations across breast cancer subtypes. Nature. 2012; 486(7403):405-9. PMC: 4148686. DOI: 10.1038/nature11154. View

13.

Tomlins S, Rhodes D, Perner S, Dhanasekaran S, Mehra R, Sun X . Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005; 310(5748):644-8. DOI: 10.1126/science.1117679. View